Economic Analysis of Pharmacogenomic-Guided Clopidogrel Treatment in Serbian Patients with Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - Concepedia

Concepedia

Publication | Closed Access

Economic Analysis of Pharmacogenomic-Guided Clopidogrel Treatment in Serbian Patients with Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

17

Citations

15

References

2016

Year

Christina Mitropoulou, V. Fragoulakis, Ljiljana Rakićević, Mirjana Novković, Athanassios Vozikis, Dragan Matić, Nebojša Antonijević, Dragica Radojković, Ron HN van Schaik, George P. Patrinos

Pharmacogenomics

Abstract

Overall, our data demonstrate that pharmacogenomics-guided clopidogrel treatment may represent a cost-saving approach for the management of myocardial infarction patients undergoing primary percutaneous coronary intervention in Serbia.

References

	Year	Citations

Page 1